1. Cancer statistics, 2021;Siegel;Ca - Cancer J. Clin.,2021
2. Global burden of multiple myeloma: a systematic analysis for the Global Burden of Disease Study 2016;Cowan;JAMA Oncol.,2018
3. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells;Hideshima;Cancer Res.,2001
4. Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma;Kuhn;Blood,2007
5. Oral therapy for multiple myeloma: ixazomib arriving soon;Moreau;Blood,2014